Antibody-directed cytotoxic agents: use of monoclonal antibody to direct the action of toxin A chains to colorectal carcinoma cells.
We have constructed cell-specific cytotoxic agens by covalently coupling the A chain from diphtheria toxin or ricin toxin to monoclonal antibody directed against a colorectal carcinoma tumor-associated antigen. Antibody 1083-17-1A was modified by attachment of 3-(2-pyridyldithio)propionyl or cystaminyl groups and then treated with reduced A chain to give disulfide-linked conjugates that retained the original binding specificity of the antibody moiety. the conjugates showed cytotoxic activity for colorectal carcinoma cells in culture, but were not toxic in the same concentration range for a variety of cell lines that lacked the antigen. Under defined conditions virtually 100% of antigen-bearing cultured cells were killed, whereas cells that lacked the antigen were not affected. Conjugates containing toxin A chains coupled to monoclonal antibodies may be useful in studying functions of various cell surface components and, possibly, as tumor-specific therapeutic agents.
D000818:Animals; D000912:Antibodies, Neoplasm; D002277:Carcinoma / Q000276:immunology*; D002470:Cell Survival; D002478:Cells, Cultured; D002999:Clone Cells / Q000276:immunology; D003110:Colonic Neoplasms / Q000276:immunology*; D004167:Diphtheria Toxin / Q000008:administration & dosage*; D006801:Humans; D051379:Mice; D009363:Neoplasm Proteins / Q000096:biosynthesis; D012276:Ricin / Q000008:administration & dosage*
D000912:Antibodies, Neoplasm; D004167:Diphtheria Toxin; D009363:Neoplasm Proteins; D012276:Ricin